[Articles] Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial

Journal content Created on 10 Jul 2026 The Lancet

• Details
• • All feed content
  • My feed content